Administration of rocuronium (Org 9426) by continuous infusion and its reversibility with anticholinesterases

The use of rocuronium (Org 9426) as a single bolus followed by an infusion was assessed in 50 patients under anaesthesia with nitrous oxide‐oxygen and halothane. Neuromuscular block was monitored using train‐of‐four stimulation and recording the force of contraction of the adductor pollicis muscle. Rocuronium was administered in an initial bolus dose of 0.45 mg.kg‐1 followed by an infusion adjusted manually to maintain the T1, the first response in the train‐of‐four, at 10% of control. Following cessation of rocuronium infusion the patients were either allowed to recover spontaneously (n = 10) or were given neostigmine 50μg.kg‐1 or edrophonium 1 mg.kg‐1 at 10 or 25% recovery of the T1 (n = 10 for each group). Adequate antagonism was defined as attaining a sustained train‐of‐four ratio of 0.7. Rocuronium requirements showed marked variation among individual patients but were relatively constant in individual patients. The mean (SD) time to attain stable infusion rates was 17.4 (10.9) min. The mean (SD) requirement of rocuronium for steady state 90% block of T1 was 572 (190) μg.kg‐1.h‐1 (range 242–1104 μg.kg‐1.h‐1). The mean (SD) time to attain a train‐of‐four ratio of 0.7 in the group allowed to recover spontaneously was 36.1 (7.3) min. This interval was 7.5 (1.9), 9.3 (7.0), 4.6 (1.9) and 1.9 (0.9) min respectively in the groups receiving neostigmine at T1 of 10%, edrophonium at T1 of 10%, neostigmine at T1 of 25% and edrophonium at T1 of 25%. The antagonism was significantly faster in those reversed at 25% (p < 0.05). Three patients in the group receiving edrophonium at T1 of 10% and one in the group receiving neostigmine at T1 of 25% failed to attain a train‐of‐four ratio of 0.7. It is concluded that rocuronium can be administered as a continuous infusion for stable neuromuscular block. Neostigmine may be a more reliable antagonist of deep block, whereas edrophonium is advantageous when there is a greater spontaneous recovery.

[1]  R. Mirakhur,et al.  Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[2]  C. Shanks,et al.  Continuous Intravenous Infusion of Rocuronium (ORG 9426) in Patients Receiving Balanced, Enflurane, or Isoflurane Anesthesia , 1993, Anesthesiology.

[3]  R. Mirakhur,et al.  Neuromuscular effects of rocuronium bromide (Org 9426) during fentanyl and halothane anaesthesia , 1993, Anaesthesia.

[4]  W. Beattie,et al.  Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[5]  B. Marsh,et al.  A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia , 1992, Anaesthesia.

[6]  R. Mirakhur,et al.  Comparison of intubating conditions after administration of Org 9246 (rocuronium) and suxamethonium. , 1992, British journal of anaesthesia.

[7]  R. Martineau,et al.  Cumulation and reversal with prolonged infusions of atracurium and vecuronium , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[8]  N. Sakuma,et al.  Effects of neostigmine and edrophonium on human erythrocyte acetylcholinesterase activity. , 1992, British Journal of Anaesthesia.

[9]  Y. Ohta,et al.  The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia. , 1991, Anesthesiology.

[10]  J. Wierda,et al.  The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl , 1991, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[11]  K. Kuizenga,et al.  Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent. , 1990, British journal of anaesthesia.

[12]  W. Bowman,et al.  Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. , 1989, British journal of anaesthesia.

[13]  H. H. Ali,et al.  Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. , 1988, British journal of anaesthesia.

[14]  W. Bowman,et al.  Structure: action Relationships Among Some Desacetoxy Analogues of Pancuronium and Vecuronium in the Anesthetized Cat , 1988, Anesthesiology.

[15]  R. Mirakhur.  Antagonism of pancuronium and tubocurarine blocks by edrophonium or neostigmine: a comparative study. , 1987, European journal of anaesthesiology.

[16]  G. Lavery,et al.  Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine. , 1987, British journal of anaesthesia.

[17]  J. Kelly,et al.  Atracurium infusions in major ophthalmic surgery. , 1987, European Journal of Anaesthesiology.

[18]  A. Kopman.  Recovery Times Following Edrophonium and Neostigmine Reversal of Pancuronium, Atracurium, and Vecuronium Steady-state Infusions , 1986, Anesthesiology.

[19]  E. Robertson,et al.  Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium. , 1986, British journal of anaesthesia.

[20]  A. Fukunaga,et al.  DOES CONJUNCTIVAL PO2 REFLECT THE CEREBRAL OXYGENATION DURING CIRCULATORY DISTURBANCES IN EXPERIMENTAL ANIMALS , 1986 .

[21]  C A Shanks,et al.  Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens. , 1986, Anesthesiology.

[22]  J. Engbaek,et al.  Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium. , 1986, Acta anaesthesiologica Scandinavica.

[23]  R. Mirakhur.  Antagonism of the muscarinic effects of edrophonium with atropine or glycopyrrolate. A comparative study. , 1985, British journal of anaesthesia.

[24]  G. Lavery,et al.  A Comparison of Edrophonium and Neostigmine for the Antagonism of Atracurium‐Induced Neuromuscular Block , 1985, Anesthesia and analgesia.

[25]  J. Viby-Mogensen,et al.  Edrophonium and Neostigmine for Reversal of the Neuromuscular Blocking Effect of Vecuronium , 1985 .

[26]  M. Rk,et al.  Muscle relaxation with an infusion of vecuronium. , 1984 .

[27]  Ronald D. Miller,et al.  NEOSTIGMINE ANTAGONIZES A PROFOUND NEUROMUSCULAR BLOCKADE MORE RAPIDLY THAN EDROPHONIUM , 1984 .

[28]  R. Mirakhur,et al.  Muscle relaxation with an infusion of vecuronium. , 1984, European journal of anaesthesiology.

[29]  R. Hughes,et al.  Infusion of atracurium for long surgical procedures. , 1984, British journal of anaesthesia.

[30]  F. Donati,et al.  Twitch Depression and Train‐of–Four Ratio after Antagonism of Pancuronium with Edrophonium, Neostigmine, or Pyridostigmine , 1983, Anesthesia and analgesia.

[31]  R. Miller,et al.  Edrophonium: Duration of Action and Atropine Requirement in Humans during Halothane Anesthesia , 1982, Anesthesiology.

[32]  R. Czerucki,et al.  Stable muscle relaxation during abdominal surgery using combined intravenous bolus and demand infusion: Clinical appraisal with ORG NC45 , 1982, Canadian Anaesthetists' Society journal.

[33]  D. Bevan,et al.  Neostigmine, Pyridostigmine, and Edrophonium as Antagonists of Pancuronium , 1980, Anesthesiology.

[34]  Aaron F. Kopman.  Edrophonium Antagonism of Pancuronium‐induced Neuromuscular Blockade in Man: A Reappraisal , 1979, Anesthesiology.

[35]  D. Bevan.  Reversal of pancuronium with edrophonium , 1979, Anaesthesia.

[36]  L. Blaber,et al.  The mechanism of the facilitatory action of edrophonium in cat skeletal muscle , 1972, British journal of pharmacology.